Top

Published in:

01-01-2015

Thiamin deficiency and heart failure: the current knowledge and gaps in literature

Authors: Mavra Ahmed, Parastoo Azizi-Namini, Andrew T. Yan, Mary Keith

Published in: Heart Failure Reviews | Issue 1/2015

Abstract

The management of heart failure (HF) represents a significant challenge for both patients as well as the healthcare system in industrialized countries. Thiamin is a required coenzyme in the energy-producing reactions that fuel myocardial contraction. Therefore, thiamin deficiency (TD) may contribute to myocardial weakness by limiting the energy available for contraction. Previous studies have reported a wide range in the prevalence of TD in patients with HF (3–91 %). The impact of thiamin supplementation in patients with HF is inconclusive. Studies conducted to date are limited by their small sample size, indirect methods of assessing thiamin concentration, methodological inconsistencies, use of impractical means of thiamin supplementation, a focus on hospitalized patients, and lack a robust technique for the assessment of cardiac function. Future large prospective studies and randomized controlled trials are needed to improve our understanding of any change in nutritional requirements associated with chronic disease as well as the clinical benefit of supplementation.

The heart and stroke foundation; statistics. http://www.heartandstroke.com/site/c.ikIQLcMWJtE/b.3483991/k.34A8/Statistics.htm. Updated 2011

de Lorgeril M, Salen P, Defaye P (2005) Importance of nutrition in chronic heart failure patients. Eur Heart J 26(21):2215–2217PubMedCrossRef

Barker J, Williams C, Tulloh R (2009) Understanding and treatment of heart failure. Paediatr Child Health 19(1):1–8CrossRef

O’Connell JB (2000) The economic burden of heart failure. Clin Cardiol 23(3 Suppl):III6–III10PubMed

Ingwall JS, Atkinson DE, Clarke K, Fetters JK (1990) Energetic correlates of cardiac failure: changes in the creatine kinase system in the failing myocardium. Eur Heart J 11(Suppl B):108–115PubMedCrossRef

Neubauer S (2007) The failing heart—an engine out of fuel. N Engl J Med 356(11):1140–1151PubMedCrossRef

Neubauer S, Horn M, Cramer M et al (1997) Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 96(7):2190–2196PubMedCrossRef

Wilkinson TJ, Hanger HC (2000) Clinical relevance of thiamine status amongst hospitalized elderly patients. Gerontology 46(5):293PubMedCrossRef

Anker SD, Steinborn W, Strassburg S (2004) Cardiac cachexia. Ann Med 36(7):518–529PubMedCrossRef

10.

Lemoine A, Le Devehat C, Codaccioni JL, Monges A, Bermond P, Salkeld RM (1980) Vitamin B1, B2, B6, and C status in hospital inpatients. Am J Clin Nutr 33(12):2595–2600PubMed

11.

Gorelik O, Almoznino-Sarafian D, Feder I et al (2003) Dietary intake of various nutrients in older patients with congestive heart failure. Cardiology 99(4):177–181PubMedCrossRef

12.

Zenuk C, Healey J, Donnelly J, Vaillancourt R, Almalki Y, Smith S (2003) Thiamine deficiency in congestive heart failure patients receiving long term furosemide therapy. Can J Clin Pharmacol 10(4):184–188PubMed

13.

Rieck J, Halkin H, Almog S et al (1999) Urinary loss of thiamine is increased by low doses of furosemide in healthy volunteers. J Lab Clin Med 134(3):238–243PubMedCrossRef

14.

Brady JA, Rock CL, Horneffer MR (1995) Thiamin status, diuretic medications, and the management of congestive heart failure. J Am Diet Assoc 95(5):541–544PubMedCrossRef

15.

McKelvie RS, Moe GW, Ezekowitz JA et al (2013) The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure. Can J Cardiol 29(2):168–181PubMedCrossRef

16.

Hunt SA, Abraham WT, Chin MH et al (2009) 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration with the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 53(15):e1–e90PubMedCrossRef

17.

McMurray JJ, Adamopoulos S, Anker SD et al (2012) European Society of Cardiology (ESC) guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the ESC, developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14(8):803–869PubMedCrossRef

18.

Shils ME, Shike M (2006) Modern nutrition in health and disease, 10th edn. Lippincott Williams & Wilkins, Philadelphia, pp 421–431

19.

Gropper SAS, Smith JL, Groff JL (2005) Advanced nutrition and human metabolism, 4th edn. Thomson/Wadsworth, Belmont, pp 275–281

20.

Ariaey-Nejad MR, Balaghi M, Baker EM, Sauberlich HE (1970) Thiamin metabolism in man. Am J Clin Nutr 23(6):764–778PubMed

21.

Health Canada (2010) Dietary reference intakes. http://www.hc-sc.gc.ca/fn-an/nutrition/reference/cons_info-guide_cons-eng.php. Updated 29 November 2010. Accessed 30 Nov 2011

22.

Baum RA, Iber FL (1984) Thiamin—the interaction of aging, alcoholism, and malabsorption in various populations. World Rev Nutr Diet 44:85–116PubMed

23.

Tanphaichitr V (2001) Thiamine. In: Rucker RB, Suttie JW, McCormick DB, Machlin LJ (eds) The handbook of vitamins, 3rd edn. Marcel Dekker Inc., New York, pp 254–282

24.

Ingwall JS, Weiss RG (2004) Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ Res 95(2):135–145PubMedCrossRef

25.

Bettendorff L (1994) Thiamine in excitable tissues: reflections on a non-cofactor role. Metab Brain Dis 9(3):183–209PubMedCrossRef

26.

Page GL, Laight D, Cummings MH (2011) Thiamine deficiency in diabetes mellitus and the impact of thiamine replacement on glucose metabolism and vascular disease. Int J Clin Pract 65(6):684–690PubMedCrossRef

27.

[No authors listed] (2003) Thiamine. Monograph. Altern Med Rev [Thiamine monograph in Alternative Medicine Review 1 February 2003]. 8(1):59–62

28.

Stipanuk MH (2000) Biochemical and physiological aspects of human nutrition. W.B. Saunders, Philadelphia, pp 475–481

29.

Butterworth RF (1993) Pathophysiologic mechanisms responsible for the reversible (thiamine-responsive) and irreversible (thiamine non-responsive) neurological symptoms of Wernicke’s encephalopathy. Drug Alcohol Rev 12(3):315–322PubMedCrossRef

30.

Finglas PM (1993) Thiamin. Int J Vitam Nutr Res 63(4):270–274PubMed

31.

Warnock LG, Prudhomme CR, Wagner C (1978) The determination of thiamin pyrophosphate in blood and other tissues, and its correlation with erythrocyte transketolase activity. J Nutr 108(3):421–427PubMed

32.

Davison AM (1998) Oxford textbook of clinical nephrology, 2nd edn. Oxford University Press, Oxford

33.

Akbarian M, Dreyfus PM (1968) Blood transketolase activity in beriberi heart disease. A useful diagnostic index. JAMA 203(1):23–26PubMedCrossRef

34.

Sauberlich HE, Dowdy RP, Skala JH (1974) Laboratory tests for the assessment of nutritional status. CRC Press, Cleveland, p 136

35.

Wood B, Gijsbers A, Goode A, Davis S, Mulholland J, Breen K (1980) A study of partial thiamin restriction in human volunteers. Am J Clin Nutr 33(4):848–861PubMed

36.

Wood B, Breen KJ, Penington DG (1977) Thiamine status in alcoholism. Aust N Z J Med 7(5):475–484PubMedCrossRef

37.

Baines M, Davies G (1988) The evaluation of erythrocyte thiamin diphosphate as an indicator of thiamin status in man, and its comparison with erythrocyte transketolase activity measurements. Ann Clin Biochem 25(Pt 6):698–705PubMedCrossRef

38.

Talwar D, Davidson H, Cooney J, St JO’Reilly D (2000) Vitamin B(1) status assessed by direct measurement of thiamin pyrophosphate in erythrocytes or whole blood by HPLC: comparison with erythrocyte transketolase activation assay. Clin Chem 46(5):704–710PubMed

39.

Mancinelli R, Ceccanti M, Guiducci MS et al (2003) Simultaneous liquid chromatographic assessment of thiamine, thiamine monophosphate and thiamine diphosphate in human erythrocytes: a study on alcoholics. J Chromatogr B: Anal Technol Biomed Life Sci 789(2):355–363CrossRef

40.

Tallaksen CM, Bohmer T, Bell H, Karlsen J (1991) Concomitant determination of thiamin and its phosphate esters in human blood and serum by high-performance liquid chromatography. J Chromatogr 564(1):127–136PubMedCrossRef

41.

Ho KK, Pinsky JL, Kannel WB, Levy D (1993) The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol 22(4 Suppl A):6A–13APubMedCrossRef

42.

Sole MJ, Jeejeebhoy KN (2002) Conditioned nutritional requirements: therapeutic relevance to heart failure. Herz 27(2):174–178PubMedCrossRef

43.

Jeejeebhoy KN, Kinney JM (1988) Nutrition and metabolism in patient care. Saunders, Philadelphia, p 797

44.

Azizi Namini P (2011) The prevalence of thiamin deficiency in ambulatory patients with heart failure [Masters of Science]. University of Toronto

45.

Seligmann H, Halkin H, Rauchfleisch S et al (1991) Thiamine deficiency in patients with congestive heart failure receiving long-term furosemide therapy: a pilot study. Am J Med 91(2):151–155PubMedCrossRef

46.

Pfitzenmeyer P, Guilland JC, d’Athis P, Petit-Marnier C, Gaudet M (1994) Thiamine status of elderly patients with cardiac failure including the effects of supplementation. Int J Vitam Nutr Res 64(2):113–118PubMed

47.

Hanninen SA, Darling PB, Sole MJ, Barr A, Keith ME (2006) The prevalence of thiamin deficiency in hospitalized patients with congestive heart failure. J Am Coll Cardiol 47(2):354–361PubMedCrossRef

48.

Shimon I, Almog S, Vered Z et al (1995) Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy. Am J Med 98(5):485–490PubMedCrossRef

49.

Havivi E, Bar On H, Reshef A, Stein P, Raz I (1991) Vitamins and trace metals status in non insulin dependent diabetes mellitus. Int J Vitam Nutr Res 61(4):328–333PubMed

50.

Thornalley PJ, Babaei-Jadidi R, Al Ali H et al (2007) High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease. Diabetologia 50(10):2164–2170PubMedCentralPubMedCrossRef

51.

Sica DA (2007) Loop diuretic therapy, thiamine balance, and heart failure. Congest Heart Fail 13(4):244–247PubMedCrossRef

52.

Anker SD, Ponikowski P, Varney S et al (1997) Wasting as independent risk factor for mortality in chronic heart failure. Lancet 349(9058):1050–1053PubMedCrossRef

53.

Obisesan TO, Toth MJ, Donaldson K et al (1996) Energy expenditure and symptom severity in men with heart failure. Am J Cardiol 77(14):1250–1252PubMedCrossRef

54.

Freeman LM, Roubenoff R (1994) The nutrition implications of cardiac cachexia. Nutr Rev 52(10):340–347PubMedCrossRef

55.

Hill GL (1992) Jonathan E. Rhoads lecture. Body composition research: implications for the practice of clinical nutrition. JPEN J Parenter Enteral Nutr 16(3):197–218PubMedCrossRef

56.

Poehlman ET, Scheffers J, Gottlieb SS, Fisher ML, Vaitekevicius P (1994) Increased resting metabolic rate in patients with congestive heart failure. Ann Intern Med 121(11):860–862PubMedCrossRef

57.

Pasini E, Aquilani R, Dioguardi FS (2008) Malnutrition and chronic heart failure. Med J Nutrition Metab 1:95–98CrossRef

58.

Wilkinson TJ, Hanger HC, George PM, Sainsbury R (2000) Is thiamine deficiency in elderly people related to age or co-morbidity? Age Ageing 29(2):111–116PubMedCrossRef

59.

O’Keeffe ST (2000) Thiamine deficiency in elderly people. Age Ageing 29(2):99–101PubMedCrossRef

60.

Bailey AL, Maisey S, Southon S, Wright AJ, Finglas PM, Fulcher RA (1997) Relationships between micronutrient intake and biochemical indicators of nutrient adequacy in a ‘free-living’ elderly UK population. Br J Nutr 77(2):225–242PubMedCrossRef

61.

Wilkinson TJ, Hanger HC, Elmslie J, George PM, Sainsbury R (1997) The response to treatment of subclinical thiamine deficiency in the elderly. Am J Clin Nutr 66(4):925–928PubMed

62.

Kwok T, Falconer-Smith JF, Potter JF, Ives DR (1992) Thiamine status of elderly patients with cardiac failure. Age Ageing 21(1):67–71PubMedCrossRef

63.

Pepersack T, Garbusinski J, Robberecht J, Beyer I, Willems D, Fuss M (1999) Clinical relevance of thiamine status amongst hospitalized elderly patients. Gerontology 45(2):96–101PubMedCrossRef

64.

Vir SC, Love AH (1977) Thiamine status of institutionalised and non-institutionalised aged. Int J Vitam Nutr Res 47(4):325–335PubMed

65.

Johnstone DE, Abdulla A, Arnold JM et al (1994) Diagnosis and management of heart failure. Canadian Cardiovascular Society. Can J Cardiol 10(6):613–631, 635–654

66.

Rocha RM, Silva GV, de Albuquerque DC, Tura BR, Albanesi Filho FM (2008) Influence of spironolactone therapy on thiamine blood levels in patients with heart failure. Arq Bras Cardiol 90(5):324–328PubMedCrossRef

67.

Packer M, Miller AB (1999) Can physicians always explain the results of clinical trials? A case study of amlodipine in heart failure. Am J Cardiol 84(4A):1L–2LPubMedCrossRef

68.

Wilson IM, Freis ED (1959) Relationship between plasma and extracellular fluid volume depletion and the antihypertensive effect of chlorothiazide. Circulation 20:1028–1036PubMedCrossRef

69.

Suter PM, Vetter W (2000) Diuretics and vitamin B1: Are diuretics a risk factor for thiamin malnutrition? Nutr Rev 58(10):319–323PubMedCrossRef

70.

Levy WC, Soine LA, Huth MM, Fishbein DP (1992) Thiamine deficiency in congestive heart failure. Am J Med 93(6):705–706PubMedCrossRef

71.

Yue QY, Beermann B, Lindstrom B, Nyquist O (1997) No difference in blood thiamine diphosphate levels between Swedish Caucasian patients with congestive heart failure treated with furosemide and patients without heart failure. J Intern Med 242(6):491–495PubMedCrossRef

72.

Hardig L, Daae C, Dellborg M, Kontny F, Bohmer T (2000) Reduced thiamine phosphate, but not thiamine diphosphate, in erythrocytes in elderly patients with congestive heart failure treated with furosemide. J Intern Med 247(5):597–600PubMedCrossRef

73.

Abou-Hashem RM, Maamoun MM, Hamza SA, Fahmy HM, Mortagy AK (2009) Thiamine level in hospitalized elderly Egyptian patients with congestive heart failure and left ventricular systolic dysfunction. J Am Geriatr Soc 57(11):2165–2166PubMedCrossRef

74.

Mendoza CE, Rodriguez F, Rosenberg DG (2003) Reversal of refractory congestive heart failure after thiamine supplementation: report of a case and review of literature. J Cardiovasc Pharmacol Ther 8(4):313–316PubMedCrossRef

75.

Saif MW (2003) Is there a role for thiamine in the management of congestive heart failure? South Med J 96(1):114–115PubMedCrossRef

76.

Ozawa H, Homma Y, Arisawa H, Fukuuchi F, Handa S (2001) Severe metabolic acidosis and heart failure due to thiamine deficiency. Nutrition 17(4):351–352PubMedCrossRef

77.

Schoenenberger AW, Schoenenberger-Berzins R, der Maur CA, Suter PM, Vergopoulos A, Erne P (2012) Thiamine supplementation in symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled, cross-over pilot study. Clin Res Cardiol 101(3):159–164PubMedCrossRef

78.

Coulston AM, Boushey CJ (eds) (2008) Nutrition in the prevention and treatment of disease, 2nd edn. Academic Press, USA

79.

Sawaya AL, Tucker K, Tsay R et al (1996) Evaluation of four methods for determining energy intake in young and older women: comparison with doubly labeled water measurements of total energy expenditure. Am J Clin Nutr 63(4):491–499PubMed

80.

Baines M, Bligh JG, Madden JS (1988) Tissue thiamin levels of hospitalised alcoholics before and after oral or parenteral vitamins. Alcohol Alcohol 23(1):49–52PubMed

81.

Herve C, Beyne P, Letteron P, Delacoux E (1995) Comparison of erythrocyte transketolase activity with thiamine and thiamine phosphate ester levels in chronic alcoholic patients. Clin Chim Acta 234(1–2):91–100PubMedCrossRef

82.

Wooley JA (2008) Characteristics of thiamin and its relevance to the management of heart failure. Nutr Clin Pract 23(5):487–493PubMedCrossRef

83.

Constantine G, Shan K, Flamm SD, Sivananthan MU (2004) Role of MRI in clinical cardiology. Lancet 363(9427):2162–2171PubMedCrossRef

84.

Lima JA, Desai MY (2004) Cardiovascular magnetic resonance imaging: current and emerging applications. J Am Coll Cardiol 44(6):1164–1171PubMedCrossRef

85.

Pennell DJ (2010) Cardiovascular magnetic resonance. Circulation 121(5):692–705PubMedCrossRef

86.

Grothues F, Smith GC, Moon JC et al (2002) Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 90(1):29–34PubMedCrossRef

87.

Bellenger NG, Burgess MI, Ray SG et al (2000) Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance. Are they interchangeable? Eur Heart J 21(16):1387–1396PubMedCrossRef

Title: Thiamin deficiency and heart failure: the current knowledge and gaps in literature
Authors: Mavra Ahmed
Parastoo Azizi-Namini
Andrew T. Yan
Mary Keith
Publication date: 01-01-2015
Publisher: Springer US
Published in: Heart Failure Reviews / Issue 1/2015
Print ISSN: 1382-4147
Electronic ISSN: 1573-7322
DOI: https://doi.org/10.1007/s10741-014-9432-0

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

At a glance: The STEP trials

Springer Medicine

Thiamin deficiency and heart failure: the current knowledge and gaps in literature

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2015

Amino acids and derivatives, a new treatment of chronic heart failure?

Bone marrow-derived mesenchymal stem cells for the treatment of heart failure

Efficacy of isolated left ventricular and biventricular pacing is differentially associated with baseline QRS duration in chronic heart failure: a meta-analysis of randomized controlled trials

Role of interleukin-6 in regulation of immune responses to remodeling after myocardial infarction

How to increase the utilization of donor hearts?

Surgical ventricular restoration: Where do we go from here?

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page